Re: Awh et al.: Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study (Ophthalmology 2015;122:162-9)
- PMID: 26398055
- DOI: 10.1016/j.ophtha.2015.02.040
Re: Awh et al.: Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study (Ophthalmology 2015;122:162-9)
Comment in
-
Reply: To PMID 25456150.Ophthalmology. 2015 Oct;122(10):e58-9. doi: 10.1016/j.ophtha.2015.03.008. Ophthalmology. 2015. PMID: 26398054 No abstract available.
-
Reply: To PMID 25200399.Ophthalmology. 2015 Oct;122(10):e59. doi: 10.1016/j.ophtha.2015.02.039. Ophthalmology. 2015. PMID: 26398056 No abstract available.
Comment on
-
Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.Ophthalmology. 2015 Jan;122(1):162-9. doi: 10.1016/j.ophtha.2014.07.049. Epub 2014 Sep 4. Ophthalmology. 2015. PMID: 25200399 Clinical Trial.
-
Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?Ophthalmology. 2015 Jan;122(1):212-5. doi: 10.1016/j.ophtha.2014.10.012. Epub 2014 Nov 18. Ophthalmology. 2015. PMID: 25456150 Free PMC article. No abstract available.
-
Should we test for genotype in deciding on age-related eye disease study supplementation?Ophthalmology. 2015 Jan;122(1):3-5. doi: 10.1016/j.ophtha.2014.10.023. Ophthalmology. 2015. PMID: 25542537 No abstract available.